The invention relates to a novel oxadiazole derivative such as acompound from the table below(see above table)or a pharmaceutically usable salt, solvate, or steroisomer thereof, or amixture thereofin any ratio. Said derivatives are kinase inhibitors and may be used to treatillnessesand complaints such as diabetes, obesity, metabolic syndrome (dyslipidaemia),systemic and pulmonal hypertonia, cardiovascular diseases and kidney diseases,anytype of fibrosis, inflammatory processes, tumours, and tumour diseases.
